Program Overview

Program Overview

The program PHAR-RWEB0010 - 055, Pharmacokinetics to improve drug therapy in understudied populations, is an online, self-paced course.

Program Details

• Program Type: Online - Self-Paced
• Dates: Nov 27, 2025 to Nov 26, 2026
• Total Learning Hours: 1.0
• Instruction Delivery Method(s): Online Self-Paced
• Course Fee(s): Registration non-credit $9.99
• CEUs: 1 CEU

Program Description

Presented by Dr. Cindy Yeung, this program addresses the issue of adverse drug reactions in newborns due to off-label use. Each year, 60 in 15,000 newborns at the Neonatal Intensive Care Unit (NICU) in Canada experience adverse drug reactions. The program highlights the impact of off-label drugs on neonates, with 90% of NICU drugs used off-label in Canada. Additionally, 22,100 mothers (10%) annually in Canada discontinue their drug therapy or breastfeeding due to uncertainty about how their medications might affect their infant.

Research Areas

The program focuses on leveraging population PK (popPK) and physiologically based PK (PBPK) modeling to predict precise doses for neonates at the NICU and estimate maternal chemical exposures to breastfeeding infants. Dr. Yeung's expertise will be applied to areas such as:

• Cardiovascular health
• Environmental toxicology
• Precision dosing

Presenter

The program is presented by Dr. Cindy Yeung, who has expertise in population PK (popPK) and physiologically based PK (PBPK) modeling.